Vanguard Group Inc Prelude Therapeutics Inc Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Vanguard Group Inc holds 1,010,392 shares of PRLD stock, worth $980,080. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,010,392

Previous 1,021,770 1.11%

Holding current value

$980,080

Previous $2.12 Million 39.34%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$0.8 - $2.04 $9,102 - $23,211	-11,378 Reduced 1.11%	1,010,392 $1.28 Million
Q3 2024 Nov 13, 2024	BUY	$2.07 - $6.37 $23,194 - $71,375	11,205 Added 1.11%	1,021,770 $2.12 Million
Q2 2024 Aug 13, 2024	SELL	$3.32 - $5.63 $21,360 - $36,223	-6,434 Reduced 0.63%	1,010,565 $3.85 Million
Q1 2024 May 10, 2024	BUY	$2.68 - $4.84 $27,183 - $49,092	10,143 Added 1.01%	1,016,999 $4.82 Million
Q4 2023 Feb 14, 2024	BUY	$1.69 - $4.37 $56,192 - $145,302	33,250 Added 3.42%	1,006,856 $4.3 Million
Q3 2023 Nov 14, 2023	BUY	$2.74 - $4.79 $56,630 - $98,999	20,668 Added 2.17%	973,606 $3.01 Million
Q2 2023 Aug 14, 2023	BUY	$4.45 - $8.12 $164,311 - $299,822	36,924 Added 4.03%	952,938 $4.29 Million
Q1 2023 May 15, 2023	BUY	$4.58 - $7.34 $76,486 - $122,578	16,700 Added 1.86%	916,014 $5.22 Million
Q4 2022 Feb 10, 2023	BUY	$4.61 - $8.5 $1,240 - $2,286	269 Added 0.03%	899,314 $5.43 Million
Q2 2022 Aug 12, 2022	BUY	$4.0 - $7.55 $394,188 - $744,029	98,547 Added 12.31%	899,045 $4.69 Million
Q1 2022 May 13, 2022	BUY	$6.9 - $13.22 $200,500 - $384,146	29,058 Added 3.77%	800,498 $5.52 Million
Q4 2021 Feb 14, 2022	SELL	$11.89 - $31.74 $4.34 Million - $11.6 Million	-365,282 Reduced 32.13%	771,440 $9.6 Million
Q3 2021 Nov 12, 2021	BUY	$25.78 - $38.65 $275,201 - $412,588	10,675 Added 0.95%	1,136,722 $35.5 Million
Q2 2021 Aug 13, 2021	BUY	$28.63 - $44.3 $32.2 Million - $49.9 Million	1,126,047 New	1,126,047 $32.2 Million

Others Institutions Holding PRLD

# of Institutions

Shares Held

30.4M

Call Options Held

6.4K

Put Options Held

View Full List

About Prelude Therapeutics Inc

Ticker PRLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,369,200
Market Cap $35.3M
Description
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...

More about PRLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Prelude Therapeutics Inc Transaction History